Concepedia

Luke McLean

LM

Statistics

Publications

10

Citations

163

H-Index

10

Active since

2019

Affiliations

The University of Melbourne(Current)

Peter MacCallum Cancer Centre

The Royal Melbourne Hospital

Luke McLean is an author at The University of Melbourne specializing in oncology, advanced cutaneous squamous cell carcinoma therapy, and medicine.

ORCID

Publications per year

2019–2024

10

Publications

10

Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma

Luke McLean, Annette M. Lim, Angela Webb et al. · Frontiers in Oncology · 2022 · 33 citations · Full text

, , +17

Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study

Luke McLean, Annette M. Lim, Mathias Bressel et al. · The Medical Journal of Australia · 2024 · 20 citations · Full text

, , +17

A phase II study of tarloxotinib (a hypoxia activated prodrug of a pan-erb tyrosine kinase inhibitor) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or skin

Luke McLean, Tessa Altair Morris, Ann Gramza et al. · Investigational New Drugs · 2022 · 19 citations · Full text

, , +16

FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma

Luke McLean, Karda Cavanagh, Rodney J. Hicks et al. · Cancer Imaging · 2021 · 17 citations · Full text

, , +17

Financial toxicity in patients with cancer attending a public Australian tertiary hospital: A pilot study

Luke McLean, Wei Hong, Sue‐Anne McLachlan · Asia-Pacific Journal of Clinical Oncology · 2020 · 16 citations

, , +14

1–5 of 10